Hollsteen
← Okta

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2017: $9.0M · 10-Q 0001628280-17-006320 filed Jun 8, 2017Research and development · Q2 FY2017: $10.0M · 10-Q 0001628280-17-009145 filed Sep 8, 2017Research and development · Q3 FY2017: $10.0M · 10-Q 0001628280-17-012165 filed Dec 7, 2017Research and development · Q4 FY2017: $11.0M · derived · 10-K 0001660134-18-000007 filed Mar 12, 2018Research and development · Q1 FY2018: $15.0M · 10-Q 0001628280-17-006320 filed Jun 8, 2017Research and development · Q2 FY2018: $17.0M · 10-Q 0001628280-17-009145 filed Sep 8, 2017Research and development · Q3 FY2018: $19.0M · 10-Q 0001628280-17-012165 filed Dec 7, 2017Research and development · Q4 FY2018: $19.0M · derived · 10-K 0001660134-19-000006 filed Mar 14, 2019Research and development · Q1 FY2019: $20.0M · 10-Q 0001660134-18-000013 filed Jun 8, 2018Research and development · Q2 FY2019: $25.0M · 10-Q 0001660134-18-000020 filed Sep 7, 2018Research and development · Q3 FY2019: $28.0M · 10-Q 0001660134-18-000023 filed Dec 6, 2018Research and development · Q4 FY2019: $30.0M · derived · 10-K 0001660134-20-000006 filed Mar 6, 2020Research and development · Q1 FY2020: $34.0M · 10-Q 0001660134-19-000012 filed May 31, 2019Research and development · Q2 FY2020: $40.0M · 10-Q 0001660134-19-000018 filed Aug 29, 2019Research and development · Q3 FY2020: $42.0M · 10-Q 0001660134-19-000026 filed Dec 6, 2019Research and development · Q4 FY2020: $43.0M · derived · 10-K 0001660134-21-000007 filed Mar 4, 2021Research and development · Q1 FY2021: $48.0M · 10-Q 0001660134-20-000012 filed May 29, 2020Research and development · Q2 FY2021: $54.0M · 10-Q 0001660134-20-000019 filed Aug 28, 2020Research and development · Q3 FY2021: $58.0M · 10-Q 0001660134-20-000026 filed Dec 3, 2020Research and development · Q4 FY2021: $62.0M · derived · 10-K 0001660134-22-000010 filed Mar 7, 2022Research and development · Q1 FY2022: $69.0M · 10-Q 0001660134-21-000013 filed May 27, 2021Research and development · Q2 FY2022: $122M · 10-Q 0001660134-21-000020 filed Sep 2, 2021Research and development · Q3 FY2022: $131M · 10-Q 0001660134-21-000026 filed Dec 2, 2021Research and development · Q4 FY2022: $147M · derived · 10-K 0001660134-23-000013 filed Mar 3, 2023Research and development · Q1 FY2023: $162M · 10-Q 0001660134-22-000026 filed Jun 3, 2022Research and development · Q2 FY2023: $156M · 10-Q 0001660134-22-000042 filed Sep 1, 2022Research and development · Q3 FY2023: $148M · 10-Q 0001660134-22-000056 filed Dec 1, 2022Research and development · Q4 FY2023: $154M · derived · 10-K 0001660134-24-000025 filed Mar 1, 2024Research and development · Q1 FY2024: $163M · 10-Q 0001660134-23-000033 filed Jun 1, 2023Research and development · Q2 FY2024: $172M · 10-Q 0001660134-23-000045 filed Aug 31, 2023Research and development · Q3 FY2024: $165M · 10-Q 0001660134-23-000068 filed Dec 1, 2023Research and development · Q4 FY2024: $156M · derived · 10-K 0001660134-25-000049 filed Mar 5, 2025Research and development · Q1 FY2025: $163M · 10-Q 0001660134-24-000088 filed May 30, 2024Research and development · Q2 FY2025: $164M · 10-Q 0001660134-24-000138 filed Aug 29, 2024Research and development · Q3 FY2025: $158M · 10-Q 0001660134-24-000168 filed Dec 4, 2024Research and development · Q4 FY2025: $157M · derived · 10-K 0001660134-26-000020 filed Mar 5, 2026Research and development · Q1 FY2026: $154M · 10-Q 0001660134-25-000093 filed May 28, 2025Research and development · Q2 FY2026: $160M · 10-Q 0001660134-25-000157 filed Aug 27, 2025Research and development · Q3 FY2026: $160M · 10-Q 0001660134-25-000171 filed Dec 3, 2025Research and development · Q4 FY2026: $165M · derived · 10-K 0001660134-26-000020 filed Mar 5, 2026Research and development · Q1 FY2027: $163M · 10-Q 0001660134-26-000051 filed May 29, 2026Research and development · Q2 FY2027: $163M · 10-Q 0001660134-26-000069 filed Aug 27, 2026163.0163.08.8Q1 FY2016Q2 FY2027Q1 FY2024
$MResearch and development · Q1 FY2023: $162M · 10-Q 0001660134-22-000026 filed Jun 3, 2022Research and development · Q2 FY2023: $156M · 10-Q 0001660134-22-000042 filed Sep 1, 2022Research and development · Q3 FY2023: $148M · 10-Q 0001660134-22-000056 filed Dec 1, 2022Research and development · Q4 FY2023: $154M · derived · 10-K 0001660134-24-000025 filed Mar 1, 2024Research and development · Q1 FY2024: $163M · 10-Q 0001660134-23-000033 filed Jun 1, 2023Research and development · Q2 FY2024: $172M · 10-Q 0001660134-23-000045 filed Aug 31, 2023Research and development · Q3 FY2024: $165M · 10-Q 0001660134-23-000068 filed Dec 1, 2023Research and development · Q4 FY2024: $156M · derived · 10-K 0001660134-25-000049 filed Mar 5, 2025163.0156.0a161.7Q1 FY2023Q4 FY2024Q1 FY2024
Q1 FY2024
163.0$M
All values (42)
PeriodValue ($M)Status
Q2 FY2027163.0reported
Q1 FY2027163.0reported
Q4 FY2026165.0derived
Q3 FY2026160.0reported
Q2 FY2026160.0reported
Q1 FY2026154.0reported
Q4 FY2025157.0derived
Q3 FY2025158.0reported
Q2 FY2025164.0reported
Q1 FY2025163.0reported
Q4 FY2024156.0derived
Q3 FY2024165.0reported
Q2 FY2024172.0reported
Q1 FY2024163.0reported
Q4 FY2023154.0derived
Q3 FY2023148.5reported
Q2 FY2023155.8reported
Q1 FY2023161.7reported
Q4 FY2022147.2derived
Q3 FY2022130.5reported
Q2 FY2022122.4reported
Q1 FY202268.9reported
Q4 FY202162.3derived
Q3 FY202158.1reported
Q2 FY202153.9reported
Q1 FY202148.5reported
Q4 FY202043.4derived
Q3 FY202041.8reported
Q2 FY202040.0reported
Q1 FY202034.0reported
Q4 FY201930.0derived
Q3 FY201927.6reported
Q2 FY201924.8reported
Q1 FY201919.9reported
Q4 FY201819.3derived
Q3 FY201819.2reported
Q2 FY201816.9reported
Q1 FY201815.4reported
Q4 FY201710.5derived
Q3 FY20179.7reported
Q2 FY20179.7reported
Q1 FY20178.8reported

4 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for Okta

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$163M
Period
Q1 FY2024, ended Apr 30, 2023 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Jun 1, 2023 · 0001660134-23-000033
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$163MJun 1, 202310-Q 0001660134-23-000033reported · confidence 1. · current